Adirondack Trust Company’s Axcelis ACLS Stock Holding History

Adirondack Trust Company’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-22	Closed	-$2.45K	–	493
2024 Q1	$2.45K	Hold	22	–	–	﹤0.01%	458
2023 Q4	$2.48K	Buy	+22	New	+$3.03K	﹤0.01%	456

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Adirondack Trust Company's ACLS Position: Q2 2024 in Review

Adirondack Trust Company sold out of Axcelis (ACLS) in Q2 2024, closing a stake of 22 shares — an estimated $2.45K sold.

Adirondack Trust Company first reported a position in ACLS in Q4 2023 and held it in 2 quarters. The position peaked at $2.48K in Q4 2023. 392 funds tracked by Wall St. Rank hold ACLS as of Q2 2024.

Adirondack Trust Company reported no remaining Axcelis position as of Q2 2024 after selling out during the quarter.
Adirondack Trust Company sold 22 Axcelis shares in Q2 2024, an estimated $2.45K.
Adirondack Trust Company first reported a position in Axcelis in Q4 2023 and held it in 2 quarters.
Adirondack Trust Company's Axcelis position peaked at $2.48K in Q4 2023.
392 funds tracked by Wall St. Rank held Axcelis as of Q2 2024.

Based on Adirondack Trust Company's 13F filing for Q2 2024, filed 9 Jul 2024.